Evidence map›Paper›PMID 27046520›Full record

ArticleGenomics2016

Practicability of detecting somatic point mutation from RNA high throughput sequencing data.

Quanhu Sheng, Shilin Zhao, Chung-I Li, Yu Shyr, Yan Guo

Abstract read
In one paragraph

Article in Genomics, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
4.0field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 41 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. RNA splicing: a dual-edged sword for hepatocellular carcinoma.Medical oncology (Northwood, London, England) · 2022
    Review
  8. Article
  9. Screening of Variants in the Transcript Profile of Eutopic Endometrium from Infertile Women with Endometriosis during the Implantation Window.Revista brasileira de ginecologia e obstetricia : revista da Federacao Brasileira das Sociedades de Ginecologia e Obstetricia · 2021
    Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

Quanhu ShengVanderbilt Ingram Cancer Center, Center for Quantitative Sciences, Nashville, TN, USA; Department of Cancer Biology, Vanderbilt University, Nashville, TN, USA.
Shilin ZhaoVanderbilt Ingram Cancer Center, Center for Quantitative Sciences, Nashville, TN, USA; Department of Cancer Biology, Vanderbilt University, Nashville, TN, USA.
Chung-I LiDepartment of Statistics, National Cheng Kung University, Taiwan.
Yu ShyrVanderbilt Ingram Cancer Center, Center for Quantitative Sciences, Nashville, TN, USA; Department of Cancer Biology, Vanderbilt University, Nashville, TN, USA; Department of Biostatistics, Vanderbilt University, Nashville, TN, USA. Electronic address: Yu.shyr@vanderbilt.edu.
Yan GuoVanderbilt Ingram Cancer Center, Center for Quantitative Sciences, Nashville, TN, USA; Department of Cancer Biology, Vanderbilt University, Nashville, TN, USA. Electronic address: Yan.guo@vanderbilt.edu.
Vanderbilt University · USNational Cheng Kung University · TW

Funding

Tumor Immunology and Microenvironment Research ProgramP30CA068485 · NCI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI MATTHEW J TYSKA · 1995 to 2026
$172.8M
Barrett's Esophagus Translational Research Network Coordinating CenterU01CA163056 · NCI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI SHYR, YU · 2011 to 2016
$2.2M
NCI NIH HHS P30 CA068485NCI NIH HHS U01 CA163056
6 · The paper itself

Abstract

Traditionally, somatic mutations are detected by examining DNA sequence. The maturity of sequencing technology has allowed researchers to screen for somatic mutations in the whole genome. Increasingly, researchers have become interested in identifying somatic mutations through RNAseq data. With this motivation, we evaluated the practicability of detecting somatic mutations from RNAseq data. Current somatic mutation calling tools were designed for DNA sequencing data. To increase performance on RNAseq data, we developed a somatic mutation caller GLMVC based on bias reduced generalized linear model for both DNA and RNA sequencing data. Through comparison with MuTect and Varscan we showed that GLMVC performed better for somatic mutation detection using exome sequencing or RNAseq data. GLMVC is freely available for download at the following website: https://github.com/shengqh/GLMVC/wiki.

Indexed as

AlgorithmsComputational BiologyExomeGenomicsHigh-Throughput Nucleotide SequencingHumansPoint MutationSequence Analysis, RNASoftwareExomeGeneralized linear modelRNAseqSomatic mutation

Identifiers

PMID27046520
PMCPMC5663213
OpenAlexW2329216661

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.